Peripheral inflammation is associated with remote global gene expression changes in the brain
Overweight adults with T2D who receive either semaglutide or standard glucose-lowering therapy (sitagliptin, empagliflozin, glipizide) Overweight adults without T2D who receive either semaglutide or usual anti-obesity drugs (Contrave, phentermine, Qsymia) The objective was to evaluate the risk of skeletal outcomes such as osteoporosis, osteoarthritis (hip and knee), gout, and other bone density disorders
Ongoing, forceful vomiting suggests overdosing or a serious adverse reaction
After one 30- to 45-minute session, most patients notice results, with improvements continuing for up to 12 weeks
Can You File an Ozempic Lawsuit
Depression, stress, and anhedonia: toward a synthesis and integrated model